Lipid-based oral formulation in capsules to improve the delivery of poorly water-soluble drugs.

Frontiers in drug delivery Pub Date : 2023-08-24 eCollection Date: 2023-01-01 DOI:10.3389/fddev.2023.1232012
Popat Mohite, Sudarshan Singh, Anil Pawar, Adinath Sangale, Bhupendra G Prajapati
{"title":"Lipid-based oral formulation in capsules to improve the delivery of poorly water-soluble drugs.","authors":"Popat Mohite, Sudarshan Singh, Anil Pawar, Adinath Sangale, Bhupendra G Prajapati","doi":"10.3389/fddev.2023.1232012","DOIUrl":null,"url":null,"abstract":"<p><p>Poorly water-soluble drugs demonstrate significant challenge in pharmaceutical development, which is linked to their limited oral bioavailability and therapeutic efficacy. To overcome these limitations, lipid-based formulations have emerged as a promising approach to enhance the delivery of such drugs. Moreover, encapsulation within capsules to provide a convenient dosage form for oral administration. The encapsulation techniques are optimized to ensure uniform drug content and efficient encapsulation efficiency. Several investigations demonstrated that the lipid-based formulations in capsules significantly improved the solubility and dissolution rate of poorly water-soluble drugs compared to non-lipid formulations. Additionally, the encapsulation of lipid-based formulations protected the drug against degradation and improved its stability. Overall, incorporating lipid-based formulations in capsules represents a promising strategy for enhancing the delivery of poorly water-soluble drugs with improvement in solubility, dissolution, stability, and bioavailability, overcoming the challenges associated with these challenging drug molecules. The review focussed a brief on utilization of lipids in capsule form to improve therapeutic efficacy of poorly soluble, dissolution and bioavailability of drugs.</p>","PeriodicalId":73079,"journal":{"name":"Frontiers in drug delivery","volume":" ","pages":"1232012"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12363274/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in drug delivery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fddev.2023.1232012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Poorly water-soluble drugs demonstrate significant challenge in pharmaceutical development, which is linked to their limited oral bioavailability and therapeutic efficacy. To overcome these limitations, lipid-based formulations have emerged as a promising approach to enhance the delivery of such drugs. Moreover, encapsulation within capsules to provide a convenient dosage form for oral administration. The encapsulation techniques are optimized to ensure uniform drug content and efficient encapsulation efficiency. Several investigations demonstrated that the lipid-based formulations in capsules significantly improved the solubility and dissolution rate of poorly water-soluble drugs compared to non-lipid formulations. Additionally, the encapsulation of lipid-based formulations protected the drug against degradation and improved its stability. Overall, incorporating lipid-based formulations in capsules represents a promising strategy for enhancing the delivery of poorly water-soluble drugs with improvement in solubility, dissolution, stability, and bioavailability, overcoming the challenges associated with these challenging drug molecules. The review focussed a brief on utilization of lipids in capsule form to improve therapeutic efficacy of poorly soluble, dissolution and bioavailability of drugs.

Abstract Image

Abstract Image

Abstract Image

基于脂质的胶囊口服制剂改善水溶性差药物的递送
水溶性差的药物由于其有限的口服生物利用度和治疗效果,在药物开发方面面临着重大挑战。为了克服这些限制,脂质为基础的配方已经成为一种有希望的方法来增强这类药物的输送。此外,包封在胶囊内以提供方便的口服给药剂型。优化包封工艺,保证药物含量均匀,包封效率高。几项研究表明,与非脂质制剂相比,胶囊中的脂质制剂显着提高了水溶性差药物的溶解度和溶出率。此外,脂基制剂的包封保护药物免受降解并提高其稳定性。总的来说,在胶囊中加入脂基制剂代表了一种很有前途的策略,可以通过改善溶解度、溶解度、稳定性和生物利用度来增强水溶性差药物的递送,克服与这些具有挑战性的药物分子相关的挑战。本文综述了脂质胶囊在提高药物难溶性、溶出性和生物利用度方面的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信